International Journal of Ophthalmology (May 2022)

Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model

  • Qian-Yi Lin,
  • Xiang-Ji Li,
  • Yu Leng,
  • Xiao-Min Zhu,
  • Min Tang,
  • Yi Lin,
  • Wang-Du Luo,
  • Bing-Cai Jiang,
  • Xia Chen,
  • Lin Xie

DOI
https://doi.org/10.18240/ijo.2022.05.02
Journal volume & issue
Vol. 15, no. 5
pp. 690 – 700

Abstract

Read online

AIM: To confirm whether exosome-mediated delivery of aptamer S58 (Exo-S58) has a better antifibrotic effect than naked S58 in human conjunctival fibroblasts (HConFs) and a rat glaucoma filtration surgery (GFS) model. METHODS: To enhance the effective reaction time of aptamer S58 in vivo, we loaded aptamer S58 into exosomes derived from HEK293T cells by PEI transfection to determine the effect of Exo-S58 in HConFs and a rat GFS model. RESULTS: Exo-S58 can significantly reduce cell proliferation, migration and fibrosis in TGF-β2-induced HConFs. In an in vivo experiment, Exo-S58 treatment prolonged filtering bleb retention and reduced fibrosis compared with naked S58 treatment in GFS rats. CONCLUSION: The exosomes are safe and valid carriers to deliver aptamers. Furthermore, Exo-S58 exhibited superior antifibrotic effect than naked S58 both in HConFs cells and rat GFS models.

Keywords